Stereotaxis Inc (STXS)

$3.05 -0.04 (-1.29%)
Market Cap 281.41M
Revenue (ttm) 26.92M
Net Income (ttm) -24.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.34%
Debt to Equity Ratio 0.00
Volume 415,500
Avg Vol 482,534
Day's Range N/A - N/A
Shares Out 91.07M
Stochastic %K 43%
Beta 1.65
Analysts Strong Sell
Price Target $4.33

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is design...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 314 678 6100
Address:
710 North Tucker Boulevard, Suite 110, Saint Louis, United States
Eddypgil
Eddypgil Oct. 27 at 4:10 PM
$STXS I’m buying on any drops to $3 or so. Pieces slowly falling into place
1 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 23 at 6:38 PM
$STXS hope he finally unloaded what he wanted to so we can resume the move back up!
1 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 23 at 2:35 PM
$STXS my thoughts is one of the approvals expected by year end should take place by nov 25th hence the closing of the last 4mil. Hopefully it comes before earnings call so they can guide better numbers as the partner is revealed and they have a credible partner who vouches for their confidence in pushing the products.
2 · Reply
RemitTekram
RemitTekram Oct. 23 at 12:46 PM
$STXS ISRG surged. We'll have ours too.
1 · Reply
zbenz
zbenz Oct. 22 at 4:13 PM
$STXS me thinks these cats are hanging at this level at high risk of a big collapse if they don't enlighten us with some very good news and real progress , aka SHOW ME , no more robo fuzzy talk on Q with half the story , gigs up at $3 SP if they don't deliver and level with share holders
0 · Reply
sldprt
sldprt Oct. 22 at 5:26 AM
$STXS this is the same as $MBOT. the difference is that $MBOT is a disposable robot. Like buying a razor blade but you don't need the razor handle. You just throw away blades without any other purchase. barriers to entry are zero. Once the soft launch in select hospitals is done. this should fly off the shelfs and spread like a virus.
2 · Reply
Algofun
Algofun Oct. 21 at 9:35 PM
$STXS Interesting after hours
1 · Reply
sldprt
sldprt Oct. 21 at 4:20 AM
$MBOT $STXS They need to take Edy the pig back. Stop coming in mbot stock. We dont want to hear your excitement. You can be bullish about STXS -73% revenue and look forward to gouging hospitals for renewables. If they can get the robot in there in the first place. MBOT is the renewable, you throw out the robot, thats the difference. Man edy pig you feel threatened because you can barely afford the toilet paper to wipe your face after eating. -73% revenue is going to dilute your a.. watch the quick exit while you sit in mbot chat. Then wonder why all your STXS friends are in there bullish.
5 · Reply
EyesOfDevilz
EyesOfDevilz Oct. 20 at 7:38 PM
$STXS If MGRM is worth $6 per shares, STXS should worth more than $6 right? Got a few thousand shares!!
0 · Reply
TonySoprano1987
TonySoprano1987 Oct. 20 at 11:41 AM
$STXS any PT for EOY. Lets guess $2.X or $3 or $4.X
1 · Reply
Latest News on STXS
Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 21, 2025, 9:00 AM EDT - 7 days ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 15, 2025, 7:32 AM EDT - 13 days ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Oct 13, 2025, 7:34 AM EDT - 15 days ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 22, 2025, 7:56 AM EDT - 5 weeks ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 8:08 AM EDT - 2 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Stereotaxis to Present at Upcoming Investor Conferences

Sep 2, 2025, 7:51 AM EDT - 2 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 28, 2025, 7:47 AM EDT - 2 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 1:24 PM EDT - 2 months ago

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Stereotaxis Reports 2025 Second Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 2 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 28, 2025, 7:48 AM EDT - 3 months ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 23, 2025, 8:00 AM EDT - 3 months ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 17, 2025, 8:32 AM EDT - 3 months ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Stereotaxis: Recurring Revenue Inflection

Jul 6, 2025, 2:13 AM EDT - 4 months ago

Stereotaxis: Recurring Revenue Inflection

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

Jul 1, 2025, 9:00 AM EDT - 4 months ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 7:04 PM EDT - 6 months ago

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

Stereotaxis Reports 2025 First Quarter Financial Results

May 12, 2025, 4:01 PM EDT - 6 months ago

Stereotaxis Reports 2025 First Quarter Financial Results

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 22, 2025, 7:00 AM EDT - 6 months ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Apr 21, 2025, 8:00 AM EDT - 6 months ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 19, 2025, 8:01 AM EDT - 7 months ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Stereotaxis to Present at 37th Annual Roth Conference

Mar 10, 2025, 8:02 AM EDT - 8 months ago

Stereotaxis to Present at 37th Annual Roth Conference

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Mar 7, 2025, 9:10 AM EST - 8 months ago

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 10:34 AM EST - 8 months ago

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:32 AM EST - 8 months ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:31 AM EST - 8 months ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Stereotaxis Reports 2024 Full Year Financial Results

Mar 3, 2025, 7:30 AM EST - 8 months ago

Stereotaxis Reports 2024 Full Year Financial Results

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 25, 2025, 8:03 AM EST - 8 months ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Feb 14, 2025, 10:41 AM EST - 9 months ago

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 3, 2025, 4:05 PM EST - 9 months ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Stereotaxis Announces First GenesisX Robotic System Order

Jan 30, 2025, 8:09 AM EST - 9 months ago

Stereotaxis Announces First GenesisX Robotic System Order

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 27, 2025, 8:00 AM EST - 9 months ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Jan 14, 2025, 7:21 AM EST - 10 months ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 9, 2024, 7:25 AM EST - 11 months ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Dec 2, 2024, 8:45 AM EST - 11 months ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Dec 2, 2024, 5:03 AM EST - 11 months ago

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 8:28 AM EST - 11 months ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 7:03 PM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Stereotaxis Reports 2024 Third Quarter Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Sep 3, 2024, 8:53 AM EDT - 1 year ago

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval

Aug 25, 2024, 7:22 PM EDT - 1 year ago

Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval

Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 11:33 PM EDT - 1 year ago

Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript

Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis Reports 2024 Second Quarter Financial Results

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Aug 12, 2024, 4:03 PM EDT - 1 year ago

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

Jul 22, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

Jul 18, 2024, 4:13 PM EDT - 1 year ago

Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

May 29, 2024, 8:25 AM EDT - 1 year ago

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory Framework

May 24, 2024, 8:37 AM EDT - 1 year ago

Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory Framework

Stereotaxis Makes A Strategic Acquisition Bolstering Its Future

May 23, 2024, 4:38 AM EDT - 1 year ago

Stereotaxis Makes A Strategic Acquisition Bolstering Its Future

Eddypgil
Eddypgil Oct. 27 at 4:10 PM
$STXS I’m buying on any drops to $3 or so. Pieces slowly falling into place
1 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 23 at 6:38 PM
$STXS hope he finally unloaded what he wanted to so we can resume the move back up!
1 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 23 at 2:35 PM
$STXS my thoughts is one of the approvals expected by year end should take place by nov 25th hence the closing of the last 4mil. Hopefully it comes before earnings call so they can guide better numbers as the partner is revealed and they have a credible partner who vouches for their confidence in pushing the products.
2 · Reply
RemitTekram
RemitTekram Oct. 23 at 12:46 PM
$STXS ISRG surged. We'll have ours too.
1 · Reply
zbenz
zbenz Oct. 22 at 4:13 PM
$STXS me thinks these cats are hanging at this level at high risk of a big collapse if they don't enlighten us with some very good news and real progress , aka SHOW ME , no more robo fuzzy talk on Q with half the story , gigs up at $3 SP if they don't deliver and level with share holders
0 · Reply
sldprt
sldprt Oct. 22 at 5:26 AM
$STXS this is the same as $MBOT. the difference is that $MBOT is a disposable robot. Like buying a razor blade but you don't need the razor handle. You just throw away blades without any other purchase. barriers to entry are zero. Once the soft launch in select hospitals is done. this should fly off the shelfs and spread like a virus.
2 · Reply
Algofun
Algofun Oct. 21 at 9:35 PM
$STXS Interesting after hours
1 · Reply
sldprt
sldprt Oct. 21 at 4:20 AM
$MBOT $STXS They need to take Edy the pig back. Stop coming in mbot stock. We dont want to hear your excitement. You can be bullish about STXS -73% revenue and look forward to gouging hospitals for renewables. If they can get the robot in there in the first place. MBOT is the renewable, you throw out the robot, thats the difference. Man edy pig you feel threatened because you can barely afford the toilet paper to wipe your face after eating. -73% revenue is going to dilute your a.. watch the quick exit while you sit in mbot chat. Then wonder why all your STXS friends are in there bullish.
5 · Reply
EyesOfDevilz
EyesOfDevilz Oct. 20 at 7:38 PM
$STXS If MGRM is worth $6 per shares, STXS should worth more than $6 right? Got a few thousand shares!!
0 · Reply
TonySoprano1987
TonySoprano1987 Oct. 20 at 11:41 AM
$STXS any PT for EOY. Lets guess $2.X or $3 or $4.X
1 · Reply
zbenz
zbenz Oct. 19 at 3:12 PM
$STXS next year could be bumpy
1 · Reply
sldprt
sldprt Oct. 18 at 8:09 PM
$STXS @Daquanladariusblackman2 What is he talking about?
1 · Reply
sldprt
sldprt Oct. 17 at 5:41 PM
$MBOT take your racist quotes somewhere else. $STXS
3 · Reply
alexpitti
alexpitti Oct. 17 at 3:47 PM
Rod Tung, said he has shoulder issues from manual procedures. Now he can use stereotaxis robots because of the mapping catheter MAGiC Sweep. $STXS
0 · Reply
zbenz
zbenz Oct. 17 at 3:10 PM
$STXS my take is that Alex is a JV like pumper who pretends to be in the know , and Eddie is just a moron , kinda funny to watch these clowns go at it
3 · Reply
Daquanladariusblackman2
Daquanladariusblackman2 Oct. 17 at 1:54 PM
$STXS oiii eddy @Eddypgil what happened to that ATH this week?
1 · Reply
sldprt
sldprt Oct. 17 at 3:44 AM
$STXS $MBOT @alexpitti @Daquanladariusblackman2 You run your mouth Alex. But we are yet to see anything intelligent come out. I see you hang out in Stocktwits, but the people on reddit seem to have a different opinion of you. It is not valued very highly. I tend to agree with them as you have demonstrated here.
3 · Reply
Mjacpa
Mjacpa Oct. 17 at 1:09 AM
Fpa for card abl. Partnership was something I did not know was in the works. It's the emerging gold standard and was a piece I thought was a large hole in their offering/roadmap The synchrony was always something David would discuss, but I didn't think a go live in 25 was actually going to happen given the looonng delays some other products/ approvals have had. Lotta catalysts in next 12 mo. Mkt cap under $300 mil.....it feels low. $STXS
0 · Reply
counter
counter Oct. 16 at 3:38 PM
$STXS
1 · Reply
sldprt
sldprt Oct. 16 at 2:43 AM
$STXS Hey $STXS Investors, I came here asking politely for some respect between groups — specifically to please keep @Eddypgil, an investor in $STXS, from coming into $MBOT discussions and spreading misinformation. Instead, I ended up getting a visit from Alex Pitti @alexpitti, the former YouTuber and Seeking Alpha content creator and also an $STXS investor. He has now come into $MBOT discussions spreading more false information. So I’m posting this here for the record: $MBOT is a good investment. The facts support that, and I’ll continue to share accurate information to keep this conversation grounded. Let’s keep things respectful between the two communities. Grats on your news.
5 · Reply
Mjacpa
Mjacpa Oct. 16 at 12:34 AM
STXS it's not too late to get long in this name. I would suggest doing so. $STXS
1 · Reply
alexpitti
alexpitti Oct. 15 at 8:18 PM
PFA collaboration with cardiofocus & Synchrony approval in europe with potential FDA approval in coming months. Big week $STXS
1 · Reply